INCOME STATEMENT
Natco Pharma Ltd.
BSE
Jul 16
1020.30
+9.40 (+ 0.93%)
Volume
140610
Prev. Close
1010.90
Open Price
1015.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 16
1021.35
+9.75 (+ 0.96%)
Volume
1677548
Prev. Close
1011.60
Open Price
1015.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE987B01026
|
Market Cap. ( ₹ in Cr. )
|
18293.39
|
P/BV
|
2.40
|
Book Value ( ₹ )
|
424.71
|
|
BSE Code
|
524816
|
52 Week High/Low ( ₹ )
|
1639/727
|
FV/ML
|
2/1
|
P/E(X)
|
9.70
|
|
NSE Code
|
NATCOPHARMEQ
|
Book Closure
|
18/02/2025
|
EPS ( ₹ )
|
105.26
|
Div Yield (%)
|
0.59
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 4094.50 | 3548.90 | 2340.80 | 1761.70 | 1617.70 |
| Other Operating Revenues | 0.00 | 20.00 | 10.20 | 6.10 | 35.80 |
| Total Operating Revenues | 4094.50 | 3568.90 | 2351.00 | 1767.80 | 1653.50 |
| | | | | | |
| Other Income | 321.30 | 104.70 | 85.50 | 94.60 | 101.10 |
| Total Revenue | 4415.80 | 3673.60 | 2436.50 | 1862.40 | 1754.60 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 536.20 | 522.50 | 475.30 | 519.20 | 372.90 |
| Purchase Of Stock-In Trade | 45.50 | 34.80 | 19.80 | 20.90 | 174.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 11.60 | 17.20 | 34.60 | -5.50 | -46.90 |
| Employee Benefit Expenses | 515.30 | 454.90 | 425.70 | 410.10 | 380.00 |
| Finance Costs | 19.60 | 14.50 | 8.60 | 13.30 | 11.30 |
| Depreciation And Amortisation Expenses | 220.00 | 171.90 | 150.90 | 138.40 | 115.20 |
| Other Expenses | 841.60 | 902.50 | 550.90 | 610.10 | 355.90 |
| Total Expenses | 2189.80 | 2118.30 | 1665.80 | 1706.50 | 1362.40 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2226.00 | 1555.30 | 770.70 | 155.90 | 392.20 |
| | | | | | |
| Profit/Loss Before Tax | 2226.00 | 1555.30 | 770.70 | 155.90 | 392.20 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 375.60 | 284.80 | 133.10 | 32.50 | 93.30 |
| Deferred Tax | 0.00 | -36.10 | 0.50 | -15.70 | -10.60 |
| Total Tax Expenses | 375.60 | 248.70 | 133.60 | 16.80 | 82.70 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 1850.40 | 1306.60 | 637.10 | 139.10 | 309.50 |
| | | | | | |
| Profit/Loss From Continuing Operations | 1850.40 | 1306.60 | 637.10 | 139.10 | 309.50 |
| | | | | | |
| Profit/Loss For The Period | 1850.40 | 1306.60 | 637.10 | 139.10 | 309.50 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 103.31 | 72.79 | 34.90 | 7.63 | 16.99 |
| Diluted EPS (Rs.) | 103.31 | 72.79 | 34.90 | 7.63 | 16.96 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 170.20 | 100.40 | 82.10 | 113.90 |
| Equity Dividend Rate (%) | 300.00 | 475.00 | 275.00 | 225.00 | 262.50 |